Follow the 큐로셀 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 큐로셀 has published 41 reports. Market capitalisation: €357.4bn. The latest transaction was filed on 2 June 2026 (Purchase). Among the most active insiders: 서현진. The full history is accessible without an account.
38
Insider Decl.
n/a
Thresholds
€3m
25 ops.
Buy Volume
€29,893
3 ops.
Sell Volume
20Σ signal
Buys €3m€29,893 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
큐로셀 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative therapies and medical solutions.